Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
25.08
-0.61 (-2.37%)
Nov 17, 2026, 3:00 PM CST

SHA:688319 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
796.18704.16588.86496.12547.48487.15
Revenue Growth
12.28%19.58%18.69%-9.38%12.38%52.18%
Gross Profit
721.29641559.09459.39504.48458.79
Operating Income
79.0432.7321.623.5114.793.89
Net Income
-32.0222.2620.7617.5626.58107.96
Earnings Per Share
-0.080.050.050.040.070.28
EPS Growth
-7.23%18.25%-33.99%-76.61%182.95%

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
161.47249.21241.66362.07359.23454.37
Total Debt
508.92433.03361.79237.61134.0338.25
Net Cash (Debt)
-347.45-183.82-120.13124.47225.2416.11
Net Cash Growth
----44.73%-45.88%381.08%
Net Cash Per Share
-0.86-0.45-0.300.310.561.08

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
18105.49-9.7344-24.5539.96
Capital Expenditures
-124.69-98.81-207.32-169.88-200.69-69.71
Free Cash Flow
-106.76.68-217.05-125.88-225.24-29.75
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.59%91.03%94.94%92.60%92.14%94.18%
Operating Margin
9.93%4.65%3.67%0.71%2.69%19.27%
Pretax Margin
3.80%4.53%3.79%3.15%7.97%22.00%
Profit Margin
-4.02%3.16%3.52%3.54%4.85%22.16%
FCF Margin
-13.40%0.95%-36.86%-25.37%-41.14%-6.11%

Dividends

Fiscal Year
FY 2023
Period EndingDec '23
Dividend Per Share
0.038
Dividend Per Share Growth
-
Dividend Yield
0.24%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-462.46207.29365.54211.50134.42
Forward PE
-187.8598.6160.7738.4459.68
P/FCF Ratio
-1540.54----
PS Ratio
12.7714.627.3112.9410.2729.79